12-32640429-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001370298.3(FGD4):c.2608A>G(p.Lys870Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000372 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K870N) has been classified as Uncertain significance.
Frequency
Consequence
NM_001370298.3 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 4HInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001370298.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FGD4 | NM_001370298.3 | MANE Select | c.2608A>G | p.Lys870Glu | missense | Exon 17 of 17 | NP_001357227.2 | ||
| FGD4 | NM_001384126.1 | c.2608A>G | p.Lys870Glu | missense | Exon 17 of 18 | NP_001371055.1 | |||
| FGD4 | NM_001304481.2 | c.2452A>G | p.Lys818Glu | missense | Exon 17 of 17 | NP_001291410.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FGD4 | ENST00000534526.7 | TSL:5 MANE Select | c.2608A>G | p.Lys870Glu | missense | Exon 17 of 17 | ENSP00000449273.1 | ||
| FGD4 | ENST00000531134.7 | TSL:2 | c.2452A>G | p.Lys818Glu | missense | Exon 17 of 17 | ENSP00000431323.1 | ||
| FGD4 | ENST00000427716.7 | TSL:2 | c.2197A>G | p.Lys733Glu | missense | Exon 18 of 18 | ENSP00000394487.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251226 AF XY: 0.0000737 show subpopulations
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74316 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2197A>G (p.K733E) alteration is located in exon 17 (coding exon 15) of the FGD4 gene. This alteration results from a A to G substitution at nucleotide position 2197, causing the lysine (K) at amino acid position 733 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Charcot-Marie-Tooth disease type 4 Uncertain:1
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 733 of the FGD4 protein (p.Lys733Glu). This variant is present in population databases (rs746459196, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with FGD4-related conditions. ClinVar contains an entry for this variant (Variation ID: 577465). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FGD4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at